Cómo citar
Resumen
Parkinson disease (PD) is the second most commonly damaging disease of the central nervous system and one of the common causes of inability in the elderly that affects quality of life. Methods: This was a randomized clinical trial study over a 6-month period of 69 patients with PD treated in Imam Reza Hospital in shiraz from April to October 2016. The patients were randomly allocated into experimental (n=34) and control (n=35). Experimental group received self-care training. The de Boer (1996) quality of life questionnaire in both groups were completed before intervention and after 1, 2-months. The quality of life questionnaire has five subscales s included Parkinson's symptoms, systemic symptoms, emotional functioning, and social function. Cronbach's alpha in all questionnaire subscales s was 0.95, SPSS (version 19) software was used to data analyses and using ANCOVA. Result: 69 patients with Parkinson disease included 36(52.17%) male and 33(47.83%) female enrolled in study. Marital status and employment status in the control and experimental group have a significant difference (respectively P=0.003 and P=0.01). It was observed self-education improved scores of quality of life subscales included Parkinson's symptoms score of in the post-test (P = 0.001), systemic symptoms in the post-test (P = 0.05). emotional function in the post-test (P = 0.05). social function score in the post-test (P = 0.05) in intervention group. There were not statistical difference of scores of quality of life in 1 month and 2 months after treatment(P>0.05).
Citas
Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, et al. Mild cognitive impairment in Parkinson disease A multicenter pooled analysis. Neurology. 2010;75(12):1062-9.
Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson's disease in the United States. Movement Disorders. 2013;28(3):311-8.
Chlond M, Bergmann F, Gí¼thlin C, Schnoor H, Larisch A, Eggert K. Patient education for patients with Parkinson”™s disease: A randomised controlled trial. Basal Ganglia. 2016;6(1):25-30.
Hindle JV. Ageing, neurodegeneration and Parkinson”™s disease. Age and ageing. 2010;39(2):156-61.
Reeve A, Simcox E, Turnbull D. Ageing and Parkinson's disease: why is advancing age the biggest risk factor? Ageing research reviews. 2014;14:19-30.
Larsen SM, Dashtipour K. Minimizing disability: An overview of the pervasiveness, clinical manifestations and treatment of depression in Parkinson's disease. Journal of Pharmacy Practice. 2008;21(4):273-7.
Wu S-Y, Wang T-F, Yu L, Jen CJ, Chuang J-I, Wu F-S, et al. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway. Brain, behavior, and immunity. 2011;25(1):135-46.
Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiology of disease. 2010;37(3):510-8.
Yokoyama H, Uchida H, Kuroiwa H, Kasahara J, Araki T. Role of glial cells in neurotoxin-induced animal models of Parkinson”™s disease. Neurological Sciences. 2011;32(1):1-7.
Kim SR, So HY, Choi E, Kang JH, Kim HY, Chung SJ. Influencing effect of non-motor symptom clusters on quality of life in Parkinson's disease. Journal of the neurological sciences. 2014;347(1):310-5.
Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72(21 Supplement 4):S1-S136.
Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. Jama. 2014;311(16):1670-83.
Martinez”Martin P, Rodriguez”Blazquez C, Kurtis MM, Chaudhuri K. The impact of non”motor symptoms on health”related quality of life of patients with Parkinson's disease. Movement Disorders. 2011;26(3):399-406.
Aghajani M, Ajorpaz NM, Atrian MK, Raofi Z, Abedi F, Vartoni SN, et al. Effect of self-care education on quality of life in patients with primary hypertension: comparing lecture and educational package. Nursing and midwifery studies. 2013;2(4):71. [in persian].
Wu Y, Guo XY, Wei QQ, Song W, Chen K, Cao B, et al. Determinants of the quality of life in Parkinson's disease: results of a cohort study from Southwest China. Journal of the neurological sciences. 2014;340(1):144-9.
A'Campo L, Wekking E, Spliethoff-Kamminga N, Le Cessie S, Roos R. The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers. Parkinsonism & related disorders. 2010;16(2):89-95.
Altuntas Y, Kement M, Gezen C, Eker H, Aydin H, Sahin F, et al. The role of group education on quality of life in patients with a stoma. European journal of cancer care. 2012;21(6):776-81.
Ardebili FM, Ghezeljeh TN, Bozorgnejad M, Zarei M, Ghorbani H, Manafi F. Effect of multimedia self-care education on quality of life in burn patients. World journal of plastic surgery. 2017;6(3):292. [in persian].
Macabasco-O”™Connell A, DeWalt DA, Broucksou KA, Hawk V, Baker DW, Schillinger D, et al. Relationship between literacy, knowledge, self-care behaviors, and heart failure-related quality of life among patients with heart failure. Journal of general internal medicine. 2011;26(9):979-86.
Khalaji H, Bahramy A, Noroozian M, Mohammadzadeh Heravi S. The effect of physical activity on functional fitness and quality of life in people with Parkinson's disease. medical journal of mashhad university of medical sciences. 2014;57(3):542-54.[in persian].
Tickle”Degnen L, Ellis T, Saint”Hilaire MH, Thomas CA, Wagenaar RC. Self”management rehabilitation and health”related quality of life in Parkinson's disease: A randomized controlled trial. Movement Disorders. 2010;25(2):194-204.
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement disorders. 2010;25(15):2649-53.
Klepac N, Trkulja V, Relja M, Babić T. Is quality of life in non”demented Parkinson”™s disease patients related to cognitive performance? A clinic”based cross”sectional study. European Journal of Neurology. 2008;15(2):128-33.
Ghaem H, Borhani Haghighi A, Zeighami B, Dehghan A. Validity and reliability of the Persian version of the Parkinson disease quality of life (PDQL) questionnaire. Journal of Kerman University of Medical Sciences. 2015. [in persian].
Hendred SK, Foster ER. Use of the World Health Organization Quality of Life assessment short version in mild to moderate parkinson disease. Archives of physical medicine and rehabilitation. 2016;97(12):2123-9. e1.
Den Oudsten BL, Van Heck GL, De Vries J. Quality of life and related concepts in Parkinson's disease: a systematic review. Movement disorders. 2007;22(11):1528-37.
Rodríguez-Violante M, Camacho-Ordoñez A, Cervantes-Arriaga A, González-Latapí P, Velázquez-Osuna S. Factors associated with the quality of life of subjects with Parkinson's disease and burden on their caregivers. Neurología (English Edition). 2015;30(5):257-63.
Chekani F, Bali V, Aparasu RR. Quality of life of patients with Parkinson's disease and neurodegenerative dementia: a nationally representative study. Research in Social and Administrative Pharmacy. 2016;12(4):604-13.
Pandey S, Bajaj BK, Wadhwa A, Anand KS. Impact of sleep quality on the quality of life of patients with Parkinson”™s disease: a questionnaire based study. Clinical neurology and neurosurgery. 2016;148:29-34.
Chang FC, Kwan V, van der Poorten D, Mahant N, Wolfe N, Ha AD, et al. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson”™s disease. Journal of Clinical Neuroscience. 2016;25:41-5.
Onozawa R, Tsugawa J, Tsuboi Y, Fukae J, Mishima T, Fujioka S. The impact of early morning off in Parkinson's disease on patient quality of life and caregiver burden. Journal of the neurological sciences. 2016;364:1-5.
Berganzo K, Tijero B, Gonzalez-Eizaguirre A, Somme J, Lezcano E, Gabilondo I, et al. Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups. Neurología (English Edition). 2016;31(9):585-91.
Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, et al. Cognitive decline and quality of life in incident Parkinson's disease: the role of attention. Parkinsonism & related disorders. 2016;27:47-53.
Hechtner MC, Vogt T, Zí¶llner Y, Schrí¶der S, Sauer JB, Binder H, et al. Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries. Parkinsonism & related disorders. 2014;20(9):969-74.
Reuther M, Spottke E, Klotsche J, Riedel O, Peter H, Berger K, et al. Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study. Parkinsonism & related disorders. 2007;13(2):108-14.
Chiong-Rivero H, Ryan GW, Flippen C, Bordelon Y, Szumski NR, Zesiewicz TA, et al. Patients”™ and caregivers”™ experiences of the impact of Parkinson”™s disease on health status. Patient related outcome measures. 2011;2:57.
Tew EH, Naismith SL, Pereira M, Lewis SJ. Quality of life in Parkinson's disease caregivers: the contribution of personality traits. BioMed research international. 2013;2013.
Carver CS, Connor-Smith J. Personality and coping. Annual review of psychology. 2010;61:679-704.
G Nurbekova, S Odanova, B Sabdenova, L Adilbekova, Z Osmanova (2018). Methods of teaching derived words of the Kazakh language by interactive technologies. Opción, Año 33, No. 85 (2018): 273-289.
KABASHEVA I.A., KHAIRULLINA A.G., I. A. RUDALEVA I.A., Analysis of scientific and technical activity resourcing in Russia, Astra Salvensis, Supplement No. 10, 2017, p. 355-365.
JV Villalobos Antúnez, FR Ganga (2016).Bioética, dignidad e intertemporalidad de los Bioderechos Humanos. Revista de Filosofía 2 (83), 7-24.
Tahavieva F.R., Nigmatullina I.A., Speech-communicative function in the structure of predictive competence of young schoolchildren with musculoskeletal disorders, Astra Salvensis, Supplement No. 10, 2017, p. 315-322.